Altamira Therapeutics Ltd. Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019
Altamira Therapeutics Ltd. (CYTOF) reported Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 of $120.00 per share for the 0-month period ending 2023-05-12, per its 20-F/A filed 2024-04-22.
Discontinued › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019 · last filed 2024-04-22
- 2023-05-12: Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 0 month $120.00.
| Period end | Weighted Average Exercise Price Of Share Options Expired In Share-based Payment Arrangement2019 0 month |
|---|---|
| 2023-05-12 | $120.00 20-F/A · filed 2024-04-22 |